Oncología

Resultados: 353
Tipo Título / Nombre Autor(es) Año
Characterization of melanoma of unknown primary in the era of immunotherapy and targeted therapy in Spain: Results from the prospective real-world study GEM 1801 Cerezuela Fuentes P, Piñero Madrona A, Muñoz Couselo E..., Ayala de Miguel P 2023
Long-term benefit of atezolizumab plus chemotherapy in extensive stage small cell lung cancer (ES-SCLC): Exploratory analysis from the IMfirst study García Campelo MR, Dómine M, Castro Carpeño J de. Moreno Vega AL..., Alonso Calderón R 2023
Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, realworld evidence in Spain (GEM 2002 - BECARE) Soria A, Sánchez Mauriño P, García Galindo R..., Ayala de Miguel P 2023
Tolerability and effectiveness of niraparib in long-term responders with platinum-sensitive recurrent ovarian cancer (GEICO-88R study) Cueva Banuelos JF, Salvador Coloma C, Gálvez Montosa F..., González Santiago S 2023
PROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Efficacy results from the pilot phase Arranz Arija JA, Piulats Rodríguez JM, Vázquez Estévez S..., Martín RC 2023
Coping strategies as mediators of uncertainty and psychological distress in patients with advanced cancer Obispo B, Cruz-Castellanos P, Fernández-Montes A, Coca-Membribes S, Rogado J..., López-Ceballos H, et al 2023
Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium Carballal S, Balaguer F, Bujanda L, Capellá G, Santiago SG, Jover R, et al 2023
The Role of Financial Difficulties as a Mediator between Physical Symptoms and Depression in Advanced Cancer Patients Lee EM, Jiménez-Fonseca P, Hernández R, Cruz-Castellanos P, Fernández-Montes A..., López-Ceballos H, et al 2023
What do patients and oncologists think about the evaluation and management of cancer?related anorexia?cachexia? The Quasar_ SEOM study Escobar Y, Ramchandani A, Castillo-Trujillo A, Martínez de Castro E..., Borrega P 2023
ATREZZO trial (SOLTI-1907): A phase II trial targeting estrogen receptor negative or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2-positive (HER2+) advanced breast cancer (ABC) - Interim analysis Ciruelos EM, Tolosa Ortega P, Salvador Bofill FJ, González Santiago S, Albacar Miro CR 2023